Testing for Hereditary Breast Cancer: Panel or Targeted Testing? Experience from a Clinical Cancer Genetics Practice

Verfasser / Beitragende:
[Jennifer Doherty, Danielle Bonadies, Ellen Matloff]
Ort, Verlag, Jahr:
2015
Enthalten in:
Journal of Genetic Counseling, 24/4(2015-08-01), 683-687
Format:
Artikel (online)
ID: 605544778
LEADER caa a22 4500
001 605544778
003 CHVBK
005 20210128100933.0
007 cr unu---uuuuu
008 210128e20150801xx s 000 0 eng
024 7 0 |a 10.1007/s10897-014-9796-2  |2 doi 
035 |a (NATIONALLICENCE)springer-10.1007/s10897-014-9796-2 
245 0 0 |a Testing for Hereditary Breast Cancer: Panel or Targeted Testing? Experience from a Clinical Cancer Genetics Practice  |h [Elektronische Daten]  |c [Jennifer Doherty, Danielle Bonadies, Ellen Matloff] 
520 3 |a Approaches to hereditary breast cancer testing are shifting as multi-gene panels become more widely available. This paper describes our center's experience and outcomes of a 6-gene panel test as a first-tier approach in patients who were candidates for BRCA testing. Between July and December 2013, a 6-gene panel test was ordered for patients meeting criteria for BRCA testing. A retrospective review detailed the mutation and variant of uncertain significance (VUS) rates for the genes analyzed. The mutation rate was 5.2% (n = 7) and the VUS rate was 6.7% (n = 9). A subsequent review determined the number of BRCA-negative patients who would have been offered additional single gene testing had BRCA, only, been their first-tier test. Applying consensus criteria revealed 7.1% (n = 9) cases that met criteria for additional testing. Pedigree analysis by a certified genetic counselor revealed 26.8% (n = 34) cases that would have been offered additional testing based on personal and/or family history. Our results suggest that this panel may be warranted as a first-tier test for a small subset of patients, but likely represents over testing for the majority of patients who are candidates for BRCA testing. The genes selected for panels, the extra costs per patient and the chance of VUS must be considered before we uniformly switch from BRCA to full panel testing on all patients. 
540 |a National Society of Genetic Counselors, Inc., 2014 
690 7 |a BRCA  |2 nationallicence 
690 7 |a Genetic testing  |2 nationallicence 
690 7 |a Panel testing  |2 nationallicence 
690 7 |a Breast cancer  |2 nationallicence 
700 1 |a Doherty  |D Jennifer  |u Cancer Genetic Counseling, Yale Cancer Center/Yale School of Medicine, 55 Church Street, Suite 402, 06510, New Haven, CT, USA  |4 aut 
700 1 |a Bonadies  |D Danielle  |u Cancer Genetic Counseling, Yale Cancer Center/Yale School of Medicine, 55 Church Street, Suite 402, 06510, New Haven, CT, USA  |4 aut 
700 1 |a Matloff  |D Ellen  |u Cancer Genetic Counseling, Yale Cancer Center/Yale School of Medicine, 55 Church Street, Suite 402, 06510, New Haven, CT, USA  |4 aut 
773 0 |t Journal of Genetic Counseling  |d Springer US; http://www.springer-ny.com  |g 24/4(2015-08-01), 683-687  |x 1059-7700  |q 24:4<683  |1 2015  |2 24  |o 10897 
856 4 0 |u https://doi.org/10.1007/s10897-014-9796-2  |q text/html  |z Onlinezugriff via DOI 
898 |a BK010053  |b XK010053  |c XK010000 
900 7 |a Metadata rights reserved  |b Springer special CC-BY-NC licence  |2 nationallicence 
908 |D 1  |a research-article  |2 jats 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-springer 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1007/s10897-014-9796-2  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Doherty  |D Jennifer  |u Cancer Genetic Counseling, Yale Cancer Center/Yale School of Medicine, 55 Church Street, Suite 402, 06510, New Haven, CT, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bonadies  |D Danielle  |u Cancer Genetic Counseling, Yale Cancer Center/Yale School of Medicine, 55 Church Street, Suite 402, 06510, New Haven, CT, USA  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Matloff  |D Ellen  |u Cancer Genetic Counseling, Yale Cancer Center/Yale School of Medicine, 55 Church Street, Suite 402, 06510, New Haven, CT, USA  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Journal of Genetic Counseling  |d Springer US; http://www.springer-ny.com  |g 24/4(2015-08-01), 683-687  |x 1059-7700  |q 24:4<683  |1 2015  |2 24  |o 10897